340B PATIENTS Act Reintroduction Expected Soon, Hospital Trade Group Challenges Drug Industry Criticisms

340B Health President and CEO Maureen Testoni speaks at the 340B Coalition's Summer Conference in National Harbor, Md. on Monday.
The leader of a major 340B hospital trade group heralded the forthcoming reintroduction of a federal bill that would codify [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Court Consolidates Drugmaker 340B Rebate Appeals, Denies Hospital Group’s Cross-Appeal Request

A federal appeals court in Washington, D.C. consolidated multiple drugmaker appeals in ongoing 340B rebate litigation.
A Washington, D.C. federal appellate court on Friday consolidated multiple drug industry appeals challenging the government’s authority to preapprove 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GSK Exempts New States from 340B Contract Pharmacy Restrictions, Teva Issues New Update on Restricted Drugs

GSK and Teva recently announced new changes to their 340B contract pharmacy restrictions.
Two major drugmakers announced new changes to their 340B contract pharmacy restrictions in notices posted to 340B ESP’s website late [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly, Indivior, Kedrion to Refund 340B Covered Entities for Overcharges, Others Announce NDC Changes

Three drugmakers recently announced refunds to 340B covered entities, while two others announced NDC changes.
Three drugmakers are offering refunds to 340B covered entities that purchased certain drugs between 2022 and 2025 following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

For the First Time, CMS Proposes Claims-Based Methods to Identify 340B Drugs Billed to Medicare Part D

CMS recently proposed two policies for identifying 340B claims billed to Medicare Part D.
In a first for the agency, the Centers for Medicare and Medicaid Services (CMS) is proposing to track 340B drugs [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Advocates Warn New CMS Proposed Rule Could Hurt 340B Program, Be ‘First Step Towards Payment Cuts’

Hospital groups and other 340B backers condemned proposals, which CMS included in its 900-plus page draft hospital outpatient prospective payment system and ambulatory surgical center rule released this week.
340B hospital advocates are raising concerns that a new Trump administration proposal to accelerate hospital outpatient payment cuts to offset [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

CMS Proposes Accelerated OPPS Cuts to Offset 340B Remedy Payments and Medicare Drug Survey That Could Lead to Significant Part B Cuts

CMS has issued a draft 2026 Hospital Outpatient Prospective Payment System (OPPS) rule, which proposes accelerated cuts to offset 340B remedy payments. The agency also proposed a controversial Medicare drug survey.
The Trump administration this week proposed accelerating hospital outpatient payment cuts to offset previous 340B hospital lump sum repayments and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Carter Introduces PBM Reform Bill That Includes 340B ‘Spread Pricing’ Reporting

U.S. Rep. Earl “Buddy” Carter (R-Ga.) unveiled the PBM Reform Act (H.R. 4317) on July 10.
U.S. Rep. Earl “Buddy” Carter (R-Ga.) recently led a bipartisan group of nearly a dozen U.S. House lawmakers in introducing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Griffith, Harshbarger Officially Take Over as E&C Health Subcommittee’s GOP Leaders

U.S. Rep. Morgan Griffith (R-Va.) and U.S. Rep Diana Harshbarger (R-Tenn.) today officially took over as the E&C Health Subcommittee's chair and vice chair, respectively.
The U.S. House Committee that oversees federal 340B policy today enacted a series of personnel shakeups, including the new chair [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmakers File New Appeal Briefs in Push to Overturn 340B Rebate Ruling

Drugmakers filed new briefs in their pending 340B rebate cases before the D.C. Circuit Court of Appeals
Four large drugmakers recently filed a pair of new briefs in their ongoing appeals of legal rulings that upheld the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live